论文部分内容阅读
目的:对我院院内制剂参芪养血颗粒防治化疗后白细胞减少的临床效果进行观察和分析。方法:选取我院于2013年1月-2014年2月份收治的96例恶性肿瘤化疗患者作为研究对象,采用随机的方法将患者均分成两组,分别为治疗组和对照组,治疗组予参芪养血颗粒口服,对照组予利可君口服,观察两组患者白细胞计数的变化情况。结果:治疗组患者的临床疗效明显好于对照组。结论:参芪养血颗粒防治化疗后白细胞减少临床疗效显著,值得在临床上推广和应用。
Objective: To observe and analyze the clinical effect of Shenqi Yangxue Granule in preventing and treating leukopenia after chemotherapy in our hospital. Methods: A total of 96 patients with malignant tumor treated in our hospital from January 2013 to February 2014 were selected as the research object. Patients were divided into two groups randomly: the treatment group and the control group, and the treatment group Qi Yangxue granule orally, the control group to riketham orally observed changes in both groups of patients with white blood cell count. Results: The clinical efficacy of the treatment group was significantly better than that of the control group. Conclusion: The clinical efficacy of Shenqi Yangxue Granule in the prevention and treatment of leukopenia after chemotherapy is significant, so it is worth to be popularized and applied clinically.